QBE have now committed to subscribe for an additional $10 million of shares compared to the original agreement. They are now investing $55 million in the conditional placement and following the raising will hold between 8.2 percent and 9.6 percent of the Company.
Thats because QBE knows the .15 cap rraising is under valued
- Forums
- ASX - By Stock
- ELD
- latest news
latest news, page-128
-
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ELD (ASX) to my watchlist
|
|||||
Last
$8.97 |
Change
0.110(1.24%) |
Mkt cap ! $1.417B |
Open | High | Low | Value | Volume |
$8.87 | $8.97 | $8.74 | $5.986M | 672.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 475 | $8.89 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$8.97 | 17762 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1314 | 8.870 |
1 | 1314 | 8.860 |
2 | 1314 | 8.850 |
1 | 1314 | 8.840 |
1 | 110000 | 8.720 |
Price($) | Vol. | No. |
---|---|---|
8.970 | 17762 | 1 |
8.980 | 2855 | 4 |
8.990 | 1314 | 1 |
9.000 | 9405 | 9 |
9.050 | 1658 | 1 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
ELD (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online